(E)-2-(3-Methoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

5-CHLORO-3-METHYL-1H-PYRAZOLO[4,3-B]PYRIDINE, 95.0%, 500mg

2-Bromo-4-methoxy-6-methylpyrimidine, 97%, 250mg

(E)-(2-Nitroprop-1-en-1-yl)benzene>98.0%(GC)25g

TERT-BUTYL 3-(PIPERIDIN-3-YL)AZETIDINE-1-CARBOXYLATE, 95.0%, 100mg

(S)-1-((BENZYLOXY)CARBONYL)PYRROLIDIN-3-YL METHANESULFONATE, 95.0%, 1g

(1R*,4R*)-N1-(2-Nitrobenzyl)cyclohexane-1,4-diamine dihydrochloride, 1g

1,2,3-Trimethoxybenzene, 99.00%, 500g

(4-Fluoro-2-isopropoxyphenyl)boronic acid, 97%, 25g

2-(2-bromoethyl)piperidine hydrobromide, 95.0%, 1g

2-Cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, 95.0%, 1g

(R)-(-)-2,2-Dimethyl-1,3-dioxolane-4-ylmethyl p-toluenesulfonate, 95.0%, 100g

Tetracloroetileno, mínimo 99,5 %, para síntesis, 2,5 L, envase de vidrio